Ibaraki, Japan

Tomoaki Iwasa

This inventor holds 1 USPTO granted patent. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomoaki Iwasa. Retrieved from https://idiyas.com/inventor/tomoaki-iwasa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Tomoaki Iwasa

Introduction

Tomoaki Iwasa is a notable inventor based in Ibaraki, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of prodrug compounds. His work is essential for advancing treatments for various medical conditions, including tumors.

Latest Patents

Tomoaki Iwasa holds a patent for a novel prodrug compound, which is useful in the treatment of tumors. The patent details a process for the preparation of these compounds, showcasing his innovative approach to drug development. He has 1 patent to his name, reflecting his commitment to advancing medical science.

Career Highlights

Iwasa is associated with Fujisawa Pharmaceutical Company, Ltd., where he has been instrumental in research and development. His work at the company has contributed to the advancement of pharmaceutical technologies and treatments.

Collaborations

Throughout his career, Tomoaki Iwasa has collaborated with notable colleagues, including Yuji Tokunaga and Hidekazu Takeno. These collaborations have fostered a productive environment for innovation and research.

Conclusion

Tomoaki Iwasa's contributions to the field of pharmaceuticals, particularly through his patent for prodrug compounds, highlight his role as an influential inventor. His work continues to impact the treatment of tumors and showcases the importance of innovation in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…